From University of Exeter: Complete Post through this link…
A promising new therapy for depression has demonstrated initial results that suggest it may be both more effective and cost-efficient than the current gold standard, CBT.
A promising new therapeutic approach for depression appears to be more cost-effective and potentially more effective than the existing gold standard of Cognitive Behavioural Therapy (CBT).
A pilot trial conducted by the University of Exeter and supported by the National Institute of Health and Care Research (NIHR) revealed that Augmented Depression Therapy (ADepT) might represent a major leap forward in treating depression. The findings were recently published in the journal EClinical Medicine.
A core feature of depression is anhedonia (reduced interest or pleasure) and well-being deficits, but current depression psychotherapies like CBT fail to adequately target these components. ADepT has been developed to pay just as much attention to building well-being as it does to reducing depressive symptoms.
